Managing Director:

Prof. Dr. Christian Klein



Heidelberg University
Institute of Pharmacy and
Molecular Biotechnology
Im Neuenheimer Feld 364
D-69120 Heidelberg

Contact (Administration):

Phone: 06221 - 54 6032
Fax: 06221 - 54 5475


Institute of Pharmacy and Molecular Biotechnology

Research at the IPMB is focussed on the development, investigation, and application of drugs and bioactive compounds, as well as on the elucidation of molecular and cellular mechanisms of action. This research integrates experimental approaches of chemistry, molecular and cellular biology, pharmacology, bioinformatics, and pharmaceutics. Main research areas of our institute include nucleic acids as tools and drug targets, development of new antiinfective drugs, molecular evolution & proteomics, research on neurodegenerative diseases, systems biology as well as drug targeting and transport.



IZN Young Investigator Award for MoBi alumnus

Max Richter was awarded this year's Chica and Heinz Schaller Young Investigator Award for his work on the molecular basis of Alzheimer's disease. His work uncovered „Distinct in vivo roles of secreted APP ectodomain variants APPsa and APPsb in regulation of spine density, synaptic plasticity, and cognition“ and was featured in the April 2018 Cover of the EMBO-Journal. Max is a Alumnus of our prestigious Program in Molecular Biotechnology and will finish his PhD in the group of Prof. Müller later this year. Congratulation!

Double success for HEIDELTEC

Twice successfully: The Team of HEIDELTEC, being located within the Institute of Pharmacy and Molecular Biotechnology (IPMB) was ranked 3rd place in the “Gründerpreis Baden-Württemberg 2018”, which was endowed with 5000,- Euro. In addition, the team won the ACHEMA-Gründerpreis 2018 (10.000,- Euro). Subject of research and development of HEIDELTEC (Dr. Silvia Pantze, Dr. Robin Tremmel, Dr. Frieder Helm und Moritz Stadler) is the creation of a solid oral dosage form for peptides and proteins, drug which otherwise can only be applied by intravenous injections. More about it in this video.

Receptor for the APP fragment APPsα discovered: publication in "The EMBO Journal"

A cleavage product of the Alzheimer's Amyloid precursor protein APP stimulates, synapse density, synaptic plasticity and memory. The secreted ectodomain of APP, known as APPsα, acts as a soluble signalling molecule on other nerve cells. A research team led by Prof. Ulrike Müller gained new insights into the molecular mechanism underlying its physiological functions and discovered a receptor for APPsα. The work was published in "The EMBO Journal“ publiziert. For more information, please refer to the website of Heidelberg university.

Computer-based Analysis of Bacteria – Publication in „Nature Communications“

The research group of PD Dr. Karl Rohr  has developed a new automatic method for analyzing live cell microscopy images of bacteria. The method was used to investigate different nutrient conditions to study the role of memory in the B. subtilis life cycle. The work was published in the journal Nature Communications

Automatic Cell Tracking in Microscopy Images – Publication in „Nature Methods“

Nature Methods. The announcement of the University of Heidelberg can be found here.

HeiDelTec on the route to success

Heidelberg Delivery Technologies, HeiDelTec GmbH, a new start-up com-pany arose from the Institute of Pharmacy and Molecular Biotechnology. After successful participation in the Exist-Research-Transfer Program of the BMWi the IPMB leads basic pharmaceutical research to practical ap-plication thus setting new pulses in the area of improving bioavailability and effectiveness of drug formulations. For further Information, follow this link.

Structure and Function of the first bacterial decapping enzyme: Publication in "Nature Chemical Biology"

group of Prof. Andres Jäschke has unraveled the structure and function of the first bacterial RNA decapping enzyme in collaboration with American scientists. Until very recently, such mechanisms were thought to occur exclusively in higher organisms, but not in bacteria. More Information can be found here: "Eine schützende Kappe für die RNA von Bakterien".


Structure of Zika virus protease and inhibitor: Publication in "Science"

​The group of Prof. Christian Klein co-authored a publication in "Science"that describes the three-dimensional structure of the Zika virus protease. This enzyme is a target protein for the discovery of antiviral drugs against Zika and related, emerging pathogens such as dengue and West Nile virus. See also: "Zika-Virus: Struktur eines Schlüsselenzyms aufgeklärt."

Protein Repairs Nerve Cell Damage





Editor: E-Mail
Latest Revision: 2018-07-09
zum Seitenanfang/up